Pharmacy teams need to connect incoming medicines with their tracing records and know what to do when the two do not agree. A useful DSCSA operating model makes those tasks clear without adding unnecessary complexity to the working day.
Connect receiving with supplier records
For medicines within DSCSA scope, FDA tells pharmacies to obtain the required tracing documentation, work promptly with suppliers when it is missing, and check the applicable licensing or registration of trading partners. See FDA’s guidance for pharmacists.
At receiving, use a short checklist:
- Match the delivery to the supplier and relevant tracing records.
- Record missing information, unexpected products, and quantity or identifier differences.
- Assign an owner for supplier follow up and document the outcome.
For electronic exchange, FDA recommends GS1 EPCIS. Applicable exemptions can change the requirements for a particular transaction. A connection to a supplier does not, by itself, confirm that all required information was received. See FDA’s product tracing questions.
Assess discrepancies and product concerns
A missing message needs investigation, but that fact alone does not establish that the medicine is illegitimate. Document the evidence and involve the designated compliance owner when a product concern arises.
Suspect product must be quarantined and investigated. If a dispenser determines, in coordination with the manufacturer, that product is illegitimate, FDA and all appropriate immediate trading partners must be notified within 24 hours of that determination. FDA’s preferred submission method is the 3911 platform in CDER NextGen; Form FDA 3911 submitted by email is also available. See FDA’s notification instructions.
Keep records retrievable
Under Section 582(d), dispensers retain tracing records for at least six years after the transaction, suspect product investigation records for at least six years after the investigation concludes, and illegitimate product disposition records for at least six years after disposition concludes.
For qualifying official tracing requests, the usual response period is two business days, unless FDA determines another reasonable period. A written arrangement for records held by a third party does not remove the dispenser’s responsibilities. See Section 582(d).
Test retrieval with an older transaction and a backup staff member. Include records held in supplier portals and retired systems.
Check the small dispenser exemption
FDA’s August 6, 2026 letter extends specified exemptions until November 27, 2027. Eligibility is based on the owning corporate entity having a total of 25 or fewer full time employees licensed as pharmacists or qualified as pharmacy technicians as of November 27, 2026.
This is not an exemption from all DSCSA responsibilities. Review the FDA exemption letter for the covered requirements, including specified verification provisions, and continue meeting obligations outside its scope.
Put the process into practice
Illustrative scenario: A delivery is missing its tracing information. Receiving records the issue, applies the applicable inventory procedure, and assigns supplier follow up. The owner confirms that the required information is accessible and records the authorized inventory decision.
The Hakile team helps dispensers define receiving routines, supplier coordination, investigation procedures, and record retrieval around their systems and staffing.